Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer

PloS One
Ji-Yeon KimKeun-Wook Lee

Abstract

We analyzed the expression levels of fluoropyrimidine-metabolizing enzymes (thymidylate synthase [TS], dihydropyrimidine dehydrogenase [DPD], thymidine phosphorylase [TP] and orotate phosphoribosyltransferase [OPRT]) to identify potential biomarkers related to treatment outcomes in gastric cancer (GC) patients receiving adjuvant S-1 chemotherapy. In this study, 184 patients who received curative gastrectomy (D2 lymph node dissection) and adjuvant S-1 were included. Immunohistochemistry and quantitative reverse transcription polymerase chain reaction were performed to measure the protein and mRNA levels of TS, DPD, TP, and OPRT in tumor tissue. In univariate analysis, low intratumoral DPD protein expression was related to poorer 5-year disease-free survival (DFS; 78% vs. 88%; P = 0.068). Low intratumoral DPD mRNA expression (1st [lowest] quartile) was also related to poorer DFS (69% vs. 90%; P < 0.001) compared to high intratumoral DPD expression (2nd to 4th quartiles). In multivariate analyses, low intratumoral DPD protein or mRNA expression was related to worse DFS (P < 0.05), irrespective of other clinical variables. TS, TP, and OPRT expression levels were not related to treatment outcomes. Severe non-hematologic toxicities (...Continue Reading

References

Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A BeckG Milano
Dec 24, 2002·Japanese Journal of Cancer Research : Gann·Hisataka FujiwaraMasakazu Fukushima
May 31, 2003·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Hisashi UsukiHajime Maeta
May 31, 2003·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Masanori TerashimaMitsukazu Gotoh
Oct 15, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H FujiwaraT Shirasaka
Jun 1, 2006·International Journal of Cancer. Journal International Du Cancer·Wataru IchikawaRenzo Hirayama
Feb 27, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H-C KwonH-J Kim
Mar 1, 2008·Cancer Chemotherapy and Pharmacology·Hidekazu KuramochiMasakazu Yamamoto
Apr 1, 2005·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Yeul Hong Kim
Oct 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mitsuru SasakoYasuo Ohashi
May 17, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N KimK-W Lee
Oct 20, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Erin M BertinoMiguel A Villalona-Calero
Jan 13, 2015·Journal of Gastric Cancer·Paul Vincent CoMelchor Demetria
Aug 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N KimK-W Lee

❮ Previous
Next ❯

Methods Mentioned

BETA
dissection

Software Mentioned

SPSS Statistics

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.